Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications patterns prevalence use vivelle® estraderm® oral premarin among women 45 years
European Society for Paediatric Infectious Diseases (ESPID) 2024 Share on: Monday, May 20 - Friday, May 24, 2024 Conference website Research coauthored by RTI Health Solutions experts will be presented at ESPID 2024. Public health impact of MENABCWY …
… Chiu K, Boller E, Bharmal M. Real-world clinical outcomes among patients with advanced Merkel cell carcinoma treated …
… A systematic literature review of immunoglobulin levels among B-cell–depleting therapies and risk of infections in …
… Director in RTI-HS’s Health Economics department, has four years of research experience focused on mathematical modelling of biological phenomena and 4 years of experience as a health economic modeller. Dr. … oncology, rheumatology, and infectious diseases, among others. …
… of recombinant zoster vaccine (RZV) in Canadians aged 50 years and older. George S, Carrico J, Hicks K, Loukov D, Kaan …
… INSEEC Paris, Paris, France Aurelie Pimienta has over 4 years of experience in market access of health technologies, … and neuropsychology, including the validation and use of a wide variety of clinical outcome assessment instruments among patients. Ms. Pimienta’s therapeutic expertise includes …
IPECAD Cross Comparison Challenge on Cost-Effectiveness Models in Alz Disease and Related Dementias William L Herring, PhD Executive Director, Health Economics Transcript As disease-modifying therapies for Alzheimer’s disease, or AD, enter the market, …
… of task. These include, but are not limited to: The use of regulatory flexibilities and supplementary data (e.g., …
… development, evaluation and implementation Treatment patterns and patient outcomes …
… development, evaluation and implementation Treatment patterns and patient outcomes …